Literature DB >> 1582691

Fatal Legionella pneumophila pneumonia: treatment failure despite early sequential oral-parenteral amoxicillin-clavulanic acid therapy.

P Hohl1, U Buser, R Frei.   

Abstract

A 68-year-old male, having just returned from a two-week holiday on the Island of Ischia, developed unilateral pneumonia for which he was treated with oral amoxicillin-clavulanic acid and hospitalized within three days when the disease worsened and spread to both lungs. Despite parenteral amoxicillin-clavulanic acid (up to 2.2 g i.v. t.i.d.) the pneumonia spread rapidly over the next three days. Sputum cultures returned post mortem yielded Legionella pneumophila serogroup 1 and urine tests revealed the presence of Legionella antigen. Disk diffusion susceptibility testing on BCYE of the causative pathogen revealed zone diameters of inhibition of the clinical isolate exceeding 50 mm, indicating high susceptibility to this antibiotic combination. The therapeutic failure of amoxicillin-clavulanic acid should stimulate further reports and studies on the efficacy against legionellosis of this drug and similar beta-lactam inhibitor combinations as well as other beta-lactamase-stable beta-lactams.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582691     DOI: 10.1007/bf01711076

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Six cases of travel-associated Legionnaires' disease in Ischia involving four countries.

Authors:  M Castellani Pastoris; P Benedetti; D Greco; E Volpi; N Billo; F J Fehrenbach; P Hohl; I Horbach; G Wewalka
Journal:  Infection       Date:  1992 Mar-Apr       Impact factor: 3.553

2.  Bactericidal effects of amoxycillin/clavulanic acid against a Legionella pneumophila pneumonia in the weanling rat.

Authors:  G M Smith; K H Abbott; M J Wilkinson; A S Beale; R Sutherland
Journal:  J Antimicrob Chemother       Date:  1991-01       Impact factor: 5.790

3.  Successful treatment of legionella pneumonia with imipenem.

Authors:  P L Chiodini; J Barker
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

4.  Exposure to Legionellaceae at a hot spring spa: a prospective clinical and serological study.

Authors:  N Bornstein; D Marmet; M Surgot; M Nowicki; A Arslan; J Esteve; J Fleurette
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

5.  In vitro antibiotic susceptibility of Legionellaceae: search for alternative antimicrobial drugs.

Authors:  W H Traub; M Spohr
Journal:  Chemotherapy       Date:  1984       Impact factor: 2.544

6.  Comparison of the activity of three antibiotic regimens in severe Legionnaires' disease.

Authors:  E Dournon; C Mayaud; M Wolff; B Schlemmer; D Samuel; J P Sollet; P Levasseur-Rajagopalan
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

7.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

8.  Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila.

Authors:  D H Stokes; B Slocombe; R Sutherland
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

9.  Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies.

Authors:  D H Stokes; M J Wilkinson; J Tyler; B Slocombe; R Sutherland
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

Review 10.  Legionella infections: a review of five years of research.

Authors:  R D Meyer
Journal:  Rev Infect Dis       Date:  1983 Mar-Apr
  10 in total
  4 in total

1.  High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.

Authors:  Lucius Chiaraviglio; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Pharmacodynamic activity of a cephalosporin, Ro 40-6890, in human skin blister fluid: antibiotic activity in concert with host defense mechanisms.

Authors:  J F Hoogkamer; W H Hesse; S Sansano; W Zimmerli
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

3.  In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.

Authors:  P H Edelstein; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 4.  Treatment of Legionnaires' disease. Current recommendations.

Authors:  J Roig; A Carreres; C Domingo
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.